A method of analysis of a certain class of experiments in carcinogenesis.

PubWeight™: 2.86‹?› | Rank: Top 1%

🔗 View Article (PMID 5954723)

Published in Biometrics on March 01, 1966

Authors

M C Pike

Articles by these authors

(truncated to the top 100)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55

Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14

A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17

Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93

Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38

Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63

Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg (1986) 3.54

Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet (1984) 3.54

Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42

Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38

Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35

Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30

Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30

Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07

Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99

Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol (1988) 2.91

Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89

Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ (1997) 2.71

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58

Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54

Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50

The long-term prognosis of severe infantile malnutrition. Lancet (1967) 2.44

Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43

Toward the primary prevention of cancer. Science (1991) 2.41

Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34

An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics (1978) 2.32

Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22

"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18

An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15

Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol (1976) 2.11

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08

Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. Biometrics (1968) 2.06

Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05

The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04

A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet (1973) 2.02

Chemoattractant receptors on phagocytic cells. Annu Rev Immunol (1984) 2.01

Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99

The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg (1986) 1.90

Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89

Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87

Slow mortality rate accelerations during aging in some animals approximate that of humans. Science (1990) 1.86

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85

Long survivals in acute leukaemia. Lancet (1973) 1.85

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res (1993) 1.82

Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol (1977) 1.81

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer (1991) 1.81

Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80

An inhibitor of macrophage chemotaxis produced by neoplasms. Science (1976) 1.79

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77

Factors in pathogenesis of central-nervous-system leukaemia. Br Med J (1972) 1.70

The epidemiology of endometrial cancer in young women. Br J Cancer (1983) 1.70

Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med (1991) 1.65

Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J Immunol (1976) 1.64

Further evidence of space-time clustering of Burkitt's lymphoma patients in the West Nile District of Uganda. Br J Cancer (1969) 1.64

The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev (1998) 1.63

Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst (1985) 1.63

Some insights into Miettinen's multivariate confounder score approach to case-control study analysis. Epidemiol Community Health (1979) 1.62

Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60

Oral contraceptive use and adenocarcinoma of cervix. Lancet (1994) 1.59

Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol (2000) 1.58

Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity. Infect Immun (1975) 1.57

ABO blood-groups in trophoblastic neoplasia. Lancet (1971) 1.56

Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res (1988) 1.56

Reserpine and breast cancer in a retirement community. N Engl J Med (1975) 1.55

Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54

From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res (1991) 1.53

An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat Res (1982) 1.52

Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst (1980) 1.52

Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption. Infect Immun (1975) 1.51

Thyroid cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer (1987) 1.50

Do regular ovulatory cycles increase breast cancer risk? Cancer (1985) 1.50

Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50

Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev (1996) 1.48

Familial breast cancer in a population-based series. Am J Epidemiol (1986) 1.44

Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer (1987) 1.44

Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst (1980) 1.43

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41

Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol (1985) 1.40

Physical fitness and subsequent myocardial infarction in healthy workers. JAMA (1983) 1.40

Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst (1996) 1.39

Cost-efficient design of a diet validation study. Am J Epidemiol (1995) 1.39

Tamoxifen to prevent breast cancer. Lancet (1990) 1.39

Evaluation of an expert system on lymph node pathology. Hum Pathol (1997) 1.38

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res (1998) 1.38

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet (1999) 1.37

Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer (1996) 1.37

Burkitt's lymphoma: a time-space cluster of cases in Bwamba County of Uganda. Br Med J (1971) 1.34

Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda. Br Med J (1967) 1.32

Hepatocellular carcinoma and oral contraceptives. Br J Cancer (1983) 1.30

Childhood leukaemia in greater London: a search for evidence of clustering. Br Med J (1967) 1.30